Stock HYL HYLORIS PHARMACEUTICALS SA
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Hyloris Pharmaceuticals SA

Insiders Hyloris Pharmaceuticals SA

Equities

HYL

BE0974363955

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:55 2023-12-08 am EST 		Intraday chart for Hyloris Pharmaceuticals SA 5-day change 1st Jan Change
12.3 EUR -1.99% -1.20% +6.03%
Dec. 04 Hyloris Pharmaceuticals Partner Gets US FDA Nod for Warts Gel MT
Oct. 26 Kye Pharmaceuticals Partners with Hyloris Pharmaceuticals for the Development and Commercialization of Atomoxetine Oral Solution in Canada CI

Insiders

Search
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hyloris Pharmaceuticals : Appoints New CFO From Bone Therapeutics
MT
Hyloris Pharmaceuticals SA Reports Consolidated Earnings Results for the Half Year Ended June 30, 2021
CI
Hyloris Pharmaceuticals SA Appoints Dietmar Aichhorn as Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Announcement Date

Since

Until

  1. Stock
  2. Equities
  3. Stock Hyloris Pharmaceuticals SA - Euronext Bruxelles
  4. News Hyloris Pharmaceuticals SA
  5. Insiders
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer